GlassScriptPhysician profile
Andrea N Meadows
NPI 1275736647
$1,782.63
in general payments reported to CMS, 2019-2025
21 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $128 · 2021: $358 · 2022: $589 · 2023: $247 · 2024: $107 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $558.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $403.58 | 2019-2025 | Pediarix, Bexsero, Rotarix |
| Corium, LLC | $326.46 | 2022-2025 | Azstarys |
| Tris Pharma INC | $202.64 | 2020-2025 | Onyda Xr |
| Ironshore Pharmaceuticals INC. | $182.90 | 2019-2022 | |
| Pfizer INC. | $117.52 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $94.92 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $81.47 | 2019-2025 | Vaxneuvance, Enflonsia, Gardasil 9 |
| Sanofi Pasteur INC. | $55.57 | 2021-2024 | |
| Kaleo, INC. | $53.34 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $45.26 | 2021-2022 | |
| Adlon Therapeutics L.P. | $43.09 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.59 | 2025 | |
| Immedica Pharma US, INC. | $21.22 | 2023 | |
| Biogen, INC. | $20.17 | 2023 | Spinraza |
| Esperion Therapeutics, INC. | $18.53 | 2024 | Nexletol |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $18.25 | 2022 | |
| Neos Therapeutics, LP | $16.75 | 2024 | Adzenys Xr-Odt |
| Alexion Pharmaceuticals, INC. | $14.86 | 2022 | |
| Hologic Sales and Service, LLC | $14.23 | 2019 | |
| Collegium Pharmaceutical, INC. | $14.21 | 2025 | Jornay Pm |
| Ultragenyx Pharmaceutical INC. | $13.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Meadows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.